Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Geriatrics | Internal Medicine | Neurology | Nursing | Pathology | Psychiatry | Journal

Back to Journal Articles

Family History of Alzheimer’s Affects Functional Connectivity

Last Updated: May 25, 2012.

 

Effect on default mode network functional connectivity seen in APOE ε4 allele noncarriers

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Cognitively normal individuals with a family history of late-onset Alzheimer's disease may display lower resting state functional connectivity in the default mode network of the brain, and this effect is detectable even in those who do not carry the apolipoprotein E ε4 allele, according to a study published online May 9 in the Annals of Neurology.

FRIDAY, May 25 (HealthDay News) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, and this effect is detectable even in those who do not carry the apolipoprotein E (APOE) ε4 allele, according to a study published online May 9 in the Annals of Neurology.

Liang Wang, M.D., of Washington University in St. Louis, and colleagues conducted a cohort study of 348 cognitively normal participants with or without a family history of late-onset AD to examine the effect of family history on the integrity of the DMN, and whether this effect is detectable in APOE ε4 noncarriers. Resting state functional connectivity magnetic resonance imaging was used to assess the integrity of the DMN.

The researchers found that patients with a family history of late-onset AD displayed reduced functional connectivity between nodes of the DMN, specifically the posterior cingulate cortex and medial temporal cortex. This was not attributable to structural atrophy in the medial temporal lobe. This effect was also seen in noncarriers of the APOE ε4 allele.

"Unknown genetic factors, embodied in a family history of late-onset AD, may affect DMN integrity prior to cognitive impairment," the authors conclude.

Several authors disclosed financial ties to the pharmaceutical industry related to the study of dementia treatments.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Probability of Long-Term Glioblastoma Survival Assessed Next: Individual Variation in Antiviral Response Present at Birth

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.